These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6888820)

  • 1. Comparison of estrogen receptors in human premenopausal and postmenopausal uteri using isoelectric focusing.
    Pellikka PA; Sullivan WP; Coulam CB; Toft DO
    Obstet Gynecol; 1983 Oct; 62(4):430-4. PubMed ID: 6888820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of estrogen receptors in human premenopausal and postmenopausal uteri: indication of biologically inactive receptor in postmenopausal uteri.
    Strathy JH; Coulam CB; Spelsberg TC
    Am J Obstet Gynecol; 1982 Feb; 142(4):372-82. PubMed ID: 7058843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the estrogen receptor from human uterus and breast tumor tissue by isoelectric focusing.
    Thibodeau SN; Sullivan WP; Jiang NS
    J Clin Endocrinol Metab; 1983 Oct; 57(4):741-8. PubMed ID: 6885963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the effect of sodium molybdate and diisopropylfluorophosphate on the human myometrial estrogen and progesterone receptors.
    Lukola A; Punnonen R
    J Steroid Biochem; 1983 Mar; 18(3):231-5. PubMed ID: 6827828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoelectric heterogeneity of human uterine estrogen binding proteins.
    Gibbons WE; Higashi M; O'Brien TJ
    J Steroid Biochem; 1983 Sep; 19(3):1291-5. PubMed ID: 6684714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear binding of estradiol in human myometrium.
    Lukola A; Lövgren T; Punnonen R
    J Steroid Biochem; 1980 Oct; 13(10):1241-8. PubMed ID: 7442251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for a reduced sulphydryl entity in the protection of molybdate-stabilized estrogen receptor.
    Ratajczak T; Samec AM; Hähnel R
    FEBS Lett; 1982 Nov; 149(1):80-4. PubMed ID: 7152037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aging on the dissociation kinetics and estradiol receptor nuclear interactions in mouse uteri: correlation with biological effects.
    Belisle S; Bellabarba D; Lehoux JG; Robel P; Baulieu EE
    Endocrinology; 1986 Feb; 118(2):750-8. PubMed ID: 3943490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molybdate and the molecular properties of the vervet monkey estrogen receptor.
    Potgieter HC; Klein T; Magagane F; Savage N; Wittliff JL
    J Steroid Biochem; 1986 Dec; 25(6):951-6. PubMed ID: 3795954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilisation of the cytoplasmic oestrogen receptor by molybdate.
    Krozowski ZS; Murphy LC
    J Steroid Biochem; 1981 Apr; 14(4):363-6. PubMed ID: 7230798
    [No Abstract]   [Full Text] [Related]  

  • 12. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethylstilbestrol binding to estrogen receptor in mammary tissue and uteri of C3H/HeJ mice.
    Okey AB; Bondy GP
    J Natl Cancer Inst; 1978 Sep; 61(3):719-24. PubMed ID: 278849
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoelectric focusing of androgen receptors from wild-type and Tfm mouse kidneys.
    Fox TO; Wieland SJ
    Endocrinology; 1981 Sep; 109(3):790-7. PubMed ID: 7262021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of two forms of molybdate-stabilized estrogen receptor.
    Ruh MF; Ruh TS
    Endocrinology; 1984 Oct; 115(4):1341-9. PubMed ID: 6479095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against a component related to soluble estrogen receptor.
    Coffer AI; Lewis KM; Brockas AJ; King RJ
    Cancer Res; 1985 Aug; 45(8):3686-93. PubMed ID: 4016746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
    Ruh MF; Brzyski RG; Strange L; Ruh TS
    Endocrinology; 1983 Jun; 112(6):2203-5. PubMed ID: 6851947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human breast tumor estrogen receptor: effects of molybdate and electrophoretic analyses.
    Miller LK; Tuazon FB; Niu EM; Sherman MR
    Endocrinology; 1981 Apr; 108(4):1369-78. PubMed ID: 7472273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.